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ALLOANTIGEN  RECEPTORS 
ON  ACTIVATED T  CELLS  IN  MICE 
I.  Binding of Alloantigens and Anti-Idiotypic Antibodies 
to the Same Receptors 
BY PETER H. KRAMMER 
(From the lnstitut fiir Irnrnunologie  und Genetik arn Deutsehen Krebeforschungszentrurn, 
Heidelberg,  West Germany) 
Antigen-specific  receptors  of B  cells  or  plasma  cells  can  easily  be  identified  as 
endogenously  synthesized  Ig molecules.  On  single  B  cells  specific Ig can directly be 
studied by autoradiography or immunofluorescence (1,  2),  and individual Ig-secreting 
plasma cells can be demonstrated in a plaque assay as performed by Jerne et al. (3). The 
nature  of the  specific T-cell receptor, however,  is still controversial (4).  In functional 
tests it could convincingly be shown that T cells have antigen specificity and therefore 
possess specific receptors for antigens (5-8). 
It would be a major advantage if one could directly study antigen-specific receptors on 
single T cells. To this end, Nagy et al. (9) have shown that stimulater cell alloantigens 
were  present  on  the  cell  surface  of mixed  lymphocyte  reaction  (MLR)  1  activated 
responder  T-cell  blasts.  The  binding  of alloantigens  was  specific  in  the  sense  that 
responder  T-cell  blasts  stimulated  by two  histogenetically  different  stimulator  cells 
bound either one or the other type of stimulator cell antigen.  This indirectly demon- 
strated  the  presence  of a  specific  T-cell  receptor  for  alloantigens.  The  same  group 
established  that  alloantigen  binding  was  dependent  on  active biosynthesis  of T-ceU 
receptors by the responder T-cell blasts (10). 
In a  different experimental system, anti-idiotypic antibodies against idiotypic deter- 
minants on T cells specific for histocompatibility antigens have been used as a probe for 
T-cell receptors. Such anti-idiotypic antibodies have most successfully been induced in 
rats  against  antihistocompatibility  antibodies  as  well  as  against  parental  T  cells 
undergoing a  graft vs. host reaction  (GvH) in F1 hybrid animals (11, 12). It has been 
difficult to use these procedures for raising similar anti-idiotypic antibodies in mice (13). 
Using  MLR-selected T-cell blasts  as antigens  in  F1  hybrid mice,  however,  we  found 
satisfactory titers of circulating anti-idiotypic antibodies. 
Binz  and  Wigzell  (12)  showed that  treatment  of MLR responder  cells with 
anti-idiotypic antibodies  and complement diminished the  ability of these cells 
to  proliferate  against  the  relevant  stimulator  cells.  It has  not  been  formally 
1  Abbreviations  used  in  this paper:  Con A, concanavalin A; FCS,  fetal bovine  serum; GvH, 
graft  vs. host reaction;  HBSS, Hanks' balanced salt  solution;  Hepos, N-2-hydroxyethylpiperazine- 
N'-2-ethane  sulfonic  acid;  LD, lymphocyte-defined  MLR-stimulating determinants; MLR, mixed 
lymphocyte reaction; MLR-activated  T-cell blasts, (B6)AKR-T,  (SJL)AKR-T,  (B6)SJL-T,  (B6) 
(AKR  ×  SJL)FI-T,  and (SJL)(AKR  ×  B6)FI-T; stimulator strain in the first,  MLR-activated 
responder T-cell  blasts  in the second position;  PBS, phosphate-buffered  saline;  RaT, rabbit anti- 
mouse T-cell  serum; SI, stimulation index. 
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demonstrated, however, that the anti-idiotypic antibodies react with the recep- 
tor molecules for alloantigens on T cells. In this paper, therefore, we studied T- 
cell receptors for alloantigens by alloantigen binding and idiotypic analysis.  In 
particular,  we tested whether anti-idiotypic antibodies and alloantigens com- 
pete for sites on the receptor molecules on T cells. Our results suggest that the 
same receptor molecules are identified by either reagent. 
Materials and Methods 
Animals.  AKR/J (H-2k),  C57B16 (B6,H-2b),  SJL/J (H-2s), and F~ hybrid mice between AKR/J 
and B6, and AKR/J and SJL/J were used. 
Media.  The culture medium for MLR was (10 mM) N-2-hydroxyethylpiperazine-N'-2-ethane 
sulfonic acid  (Hepes)-buffered  RPMI-1640  (Grand  Island  Biological Co.,  Grand  Island,  N.  Y.) 
supplemented  with  L-glutamine  (2  mM  final  concentration),  streptomycin  (100  ~g/ml),  5% 
human  serum  (a  pretested  batch  which  allowed  high  stimulation  in  MLR  and  kept  the 
[3H]thymidine uptake in syngeneic MLR cultures low), and 2-mercaptoethanol  (3 ×  10 -5 M final 
concentration). The medium used for the preparation of cell suspensions and washing of cells was 
the same except that it did not contain 2-mercaptoethanol. The concentration of human serum in 
this medium was 2.5% (wash medium). 
Immunofiuorescence was performed in Hanks' balanced salt solution (HBSS) with 10% fetal 
calf serum (FCS) (heat inactivated) and 10 -2 M Na-azide. 
Cell Preparation for MLR Cultures.  Lymph node cells from axillary, cervical, inguinal,  and 
mesenteric  nodes  were  prepared  as  described  previously  (14).  The  cells  were  counted  and 
viability  was  determined  by  exclusion  of trypan  blue  0.16%  in  saline.  Responder  cells  were 
enriched for T cells by passing normal lymph node cells over nylon wool columns.  Greater than 
99% of the nonadherent cells were Ig-negative (as tested by immunofluorescence; between 38% 
and 71% of the cells loaded on the column were recovered). 
Nylon Wool Column Procedure.  The method was a modification of that described by Julius et 
al.  (15).  10-ml  plastic  Luer  lock  syringes  were  densely  packed  with  1.6  g  nylon  woo].  (LP-1 
Leukopak  filter;  Fenwal  Inc.,  Walter  Kidde  &  Co.,  Inc.,  Ashland,  Mass.)  and  sterilized  by 
autoclaving.  Before use,  the columns were washed with 50 ml phosphate-buffered saline  (PBS) 
and 10 ml PBS containing 5% heat-inactivated FCS. The column was then incubated for at least 
1 h at 37°C. After incubation, the column was washed with 50 ml PBS containing 5% FCS (37°C). 
Up to 1.25  ×  108 lymph node cells in 2 ml of PBS containing 5% FCS were applied to the column. 
2 ml of PBS containing 5% FCS were used to wash the cells farther into the column (drop by drop). 
After 45 min of incubation at 37°C, the nonadherent cells were washed out of the column with 50 
ml of prewarmed (37°C) wash medium. 
MLR.  Unidirectional MLR cultures were set up in the following way. Stimulator cells were 
X-irradiated  (3,300  tad).  The  respender  cells were  nylon  wool  column-separated  lymph  node 
cells. The concentration of respender cells was adjusted to 5  ×  10  e cells/ml, that  of stimulator 
cells to 1  ×  107 cells/ml. 2 ml of respender cell suspension was mixed with an equal volume of 
stimulator cell suspension  (ratio 1:2) in a  Falcon 30-ml plastic bottle (no.  3012; Falcon Plastics, 
Div. of BioQuest, Oxnard, Calif.). The bottles were incubated in an upright position in a 5% CO2- 
95% air humidified atmosphere for 4 days. Aider 3 days, 40 ~Ci of [3H]thymidine (2 Ci/nmol; The 
Radiochemical  Centre,  Amersham,  England)  was  added  and  thymidine  incorporation  was 
determined on day 4 of culture.  The stimulation index was calculated as the ratio of counts in 
allogeneic cultures to counts in syngeneic cultures, 
Mitogen Activation.  Spleen cells (5 x  108 cells/ml) in the same medium as that used for MLR 
cultures  were stimulated  for 2  days  with  5  ~g or  10  ~g concanavalin A  (Con A; Boehringer/ 
Mannheim,  no.  15237) per ml medium.  [3H]Thymidine incorporation was measured after a  24-h 
labeling period. 
Preparation of Blasts.  Blasts were recovered from MLR cultures on day 4 by centrifuging 5 
ml of cultured cells over a 4-ml Ficoll-Urovisen layer (density 1.077 g/cmS; Schering AG, Berlin, 
West Germany) in siliconized 12-ml glass tubes at 600 g  for 15 rain at room temperature.  Cells 
(at  least  98%  viable) were recovered from the  interface  and  washed  three  times in  medium. 
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sized blasts. Blast cells were defined as cells with a diameter at least twice that of a small lympho- 
cyte,  with a  smaller nuclear-to-cytoplasmic ratio than small lympbocytes,  and with a  nonseg- 
mented nucleus (as distinct from nonlymphoid cells). 
Alloantigen Binding Assay.  The method used to detect specific rebinding of alloantigeus to 
trypsinized T-cell blasts was similar to that described by Elliott et al.  (10).  The following stops 
were sequentially undertaken to perform the complete assay:  (a) isolation of MLR-activated T- 
cell  blasts;  (b)  identification of these  blasts as  respender  T  cells with bound stimulator cell 
alloantigens; (c) trypsin treatment ofT-cell blasts. The T cell blasts were washed twice in RPMI- 
1640 with 0.03 M  Hepes and 5% heat-inactivated FCS (Gibco Diagnostics, Chagrin Falls, Ohio), 
counted, washed once more in RPMI-1640 without serum or Hepes, and resuspended in HBSS to 
a  concentration of 2  ×  107 cells/ml. To 0.2-1 ml of each cell suspension, an equal volume of PBS 
containing 5 mg/ml tosyl-L-phenylalanyl-chlormethane-treated trypsin (Merck AG, Darmstadt, 
West Germany) was added, and the mixture was then incubated at 37°C for 30 min. To stop the 
reaction,  ice-cold  RPMI-1640  (10  ml)  with  15%  FCS  was  added;  the  cells  were  counted,  and 
washed three times.  To enable them to recover from trypsin treatment,  the T-cell blasts were 
cultured at a concentration of 5  x  105 cells/ml overnight at 37°C,  in 5% CO2, and in a humidifed 
atmosphere in fresh culture medium in Falcon flasks (model 3012); (d) rebinding of alloantigens 
to  trypsin  treated  blasts.  After  overnight incubation,  the  trypsin-treated  cells were  counted, 
washed once, and resuspended to 1.5 ×  10  e viable cells/ml; 0.3-ml aliquots of this cell suspension 
were  incubated  for  5  h  with  0.7  ml  of fresh  tissue  culture  medium,  or  medium  containing 
alloantigens (stimulator cell material). Afterwards, the cells were counted again. Allogeneic cell 
material bound by the recovered responder T-cell blasts was detected by indirect immunofluores- 
cence after the cells had been incubated first with antistimulator alloantiserum, and then with 
fluorescent  anti-mouse  Ig  antibodies.  As  a  source  of  stimulator  cell  material,  we  used  the 
supernate from 4-day MLR cultures collected after centrifuging the whole culture twice at 400 g 
for 10 min. 
Competition of Alloantigens and Anti-Idiotypic Antibodies for Receptors on MLR-Activated T 
Cell Blasts.  MLR-activated T-cell blasts were incubated overnight after trypsin treatment with 
MLR  supernates  (as  a  source  of alloantigens) from allogeneic  or  syngeneic MLR cultures,  as 
described above.  Indirect fluorescent staining of the recovered blasts with anti-idiotypic serum 
and fluorescent anti-mouse Ig antibodies (see below) was performed the next day. 
Hyperimmune  Alloantisera.  AKR  anti-B6,  AKR  anti-SJL,  and  B6  anti-AKR were  raised, 
absorbed, and tested for specificity as previously described (9, 16). 
Normal Mouse Sera.  Normal mouse sera used were a pool of serum from 20-30 mice. All sera 
were heat inactivated (56°C,  30 min). 
Rabbit Anti-Mouse T-CeU Serum (RAT).  RaT serum was a gift from Dr. C. Bron, Institut de 
Biochimie, Universit~ de Lausanne, Switzerland (17). 
Anti-Idiotypic Sera.  The principle of the production of anti-idiotypic sera was the injection of 
isolated  MLR-activated T-cell  blasts  into  F1  mice  (crosses between respender  and  stimulater 
strains). This is illustrated by the following example. The isolated (B6) AKR-T cell blasts were 
washed five times in 10 ml HBSS and injected intraperitoneally into 13  (AKR  x  B6)F~  hybrid 
mice. Each mouse was given three injections of isolated T-cell blasts: (a) 1 ×  10  ~ cells in complete 
Freund's adjuvant; (b) 5 ×  105 cells in incomplete Freund's adjuvant (1-wk interval); (c) 3.5 ×  10  ~ 
cells in incomplete Freund's adjuvant  (2-wk interval). The sera used in our experiments gave 
essentially the same results.  They were a  pool from a  bleeding of all 13  (AKR  ×  B6)F1 hybrid 
mice obtained 2 and 3 wk after the last injection, respectively. The sera will be referred to as F~ 
anti-(AKR anti-B6) sera, in short F~a(AKRaB6). 
Absorption  ofAnti-ldiotypic Sera.  50  fzl of the sera  (at a  predetermined dilution in HBSS) 
was mixed with 8 ×  10  e T-cell blasts resuspended in a known volume of HBSS. This mixture was 
incubated for 30 min on ice, the cells were spun down for 10 min at 16,000 g, and the serum was 
recovered. The dilution was then calculated. This procedure was repeated twice. 
Absorption of Fla(AKRaB6) Serum on Alloantisera.  0.8 ml each of normal AKR serum, and 
hyperimmune AKR anti-SJL, and AKR anti-B6 sera were coupled to 2.7 g (wet weight) cyanogen 
bromide-activated  Sepharose  4B  (Pharmacia  Inc.,  Piscataway,  N.J.)  according to  the  method 
described by March et al.  (18).  100 btl of (SJL)AKR-T cell blast-preabsorbed F~a(AKRaB6) serum 
(see above) was absorbed for 1 h  at 4°C with 100/zl of packed, coupled Sepharose. The absorbed 
F,a(AKRaB6)  serum  was  recovered  by  centrifugation of the  mixture  at  16,000 g  for  10  min. 28  T~CELL  RECEPTORS  FOR  ALLOANTIGENS 
Special care was taken that the absorbed sera had exactly the same dilution when used to stain 
(B6)AKR-T cell blasts in indirect immunofluorescence. 
Immunofluorescence.  The cells were washed three times in fluorescence medium at 4°C,  and 
were kept throughout in this medium. They were resuspended in 100 ~1 of medium to which 100 
~1 of the appropriate fluorescent reagent was added (at a  predetermined dilution), incubated at 
4°C  for 30 rain,  and washed  three  times between each  incubation.  A~r  the final  antiserum 
treatment, the cells were washed three times and mounted on glass slides: the preparations were 
scored under a  Zeiss fluorescence microscope (Photomik HI; Carl Zeiss, Inc., New York). 
Ig÷T ÷ blasts were detected by treating the cells simultaneously with rabbit anti-mouse T-cell 
serum (dilution 1/400) and the appropriate mouse antiserum was detected by tetramethylrhoda- 
mine isothiocyanate-conjugated sheep anti-rabbit IgG and fluorescein isothiocyanate-conjugated 
sheep  anti-mouse  IgG.  The  anti-Ig  sera  were  raised  and  conjugated  with  fluorochromes  as 
described  (19),  with the modification that in all cases only fluorescent anti-Ig antibodies were 
used which were purified by affinity chromatography on Ig columns  (20)  before coupling with 
fluorochromes. All sera as well as all fluorescent conjugates were centrifuged at 16,000 g  for 10 
min immediately before use. 
Results 
Specific  Rebinding of Alloantigens  to  MLR-Activated  T-Cell Blasts  after 
Removal  of Cell  Surface-Bound  Stimulator  Cell  Alloantigens  by  Trypsin 
Treatment.  Specific  rebinding  of  stimulator  cell  alloantigens  to  trypsin- 
treated,  MLR-activated  responder T-cell  blasts  after recovery from  trypsin 
treatment is shown in Table I. The data in this table are from one representative 
experiment out of three which gave essentially the same results. We used AKR 
as responders and B6 and SJL as stimulators in MLR, as these strains show a 
large  number of histocompatibility differences (21). Trypsin treatment and 
overnight incubation in MLR culture medium (without alloantigens) of MLR- 
activated AKR responder T-cell blasts reduced the number of these cells which 
could be stained with responder anti-stimulator serum to a level below 5%. 52% 
of (B6)AKR-T  cell blasts bound B6 and only 10%  SJL alloantigens; this was 
significantly above background staining with normal mouse serum instead of 
alloantiserum. (SJL)AKR-T cell blasts revealed the reverse specificity, i.e. 57% 
of these  blasts  bound  SJL  and  only  14%  bound  B6  alloantigens.  Control 
staining with normal mouse sera instead of alloantisera gave fewer than 3% 
Ig+T  + blasts. 
Reactivity  of Anti-Idiotypic  Antibodies with MLR- or Mitogen-Activated  T 
Cells.  As  shown  above,  a  large number of (B6)AKR-T  cell blasts  had  B6 
alloantigens bound,  possibly  to  receptors on  the  cell  surface.  We  therefore 
raised anti-idiotypic antibodies by injection of these blasts into (AKR ×  B6)F~ 
hybrid mice.  We  used this  combination to  avoid production of alloantibody 
(anti-B6 antibodies). These antibodies could in principle be generated if synge- 
neic (i.e. AKR) mice were used as recipients. 
With the Fla(AKRaB6) sera normal B6, (AKR × B6)F1, and (AKR × SJL)F1 
lymph node T cells did not stain above background in comparison to controls 
with normal (AKR  ×  B6)FI serum. Conversely, normal AKR lymph node T 
cells stained minimally above background. An exact estimate of the precursor 
frequency of idiotype-positive AKR T cells, however, cannot be given with the 
immunofluorescent  method due to the difficulty in establishing the significance 
of a low number of positive cells above background. 
The results from Table II demonstrate that the majority (65%) of (B6)AKR-T PETER  H.  KRAMMER  29 
TA~L~.  I 
Specific Rebinding of Alloantigens  from MLR Supernates  to MLR-Activated 
Trypeinized  T-Cell Blasts after Recovery from Trypsin  Treatment 
T-cell  blasts  from MLR* 
Responder  Stimulator  Responder  Stimulator 
Trypsinized T-cell  blasts  incu- 
bated with supernates from  Alloantisera$ for  detec- Ig-positive 
MLR  tion  of  bound alloanti-  responder 
T-cell 
gens  blasts§ 
% 
AKR  B6  (i)  AKRII  B6  AKR  anti-B6  52 
AKR  B6  (ii)  AKRII  SJL  AKR  anti-SJL  i0 
AKR  SJL  (iii)  AKRII  SJL  AKR  anti-SJL  57 
AKR  SJL  (iv)  AKRII  B6  AKR  anti-B6  14 
* Responder cells were nylon wool column-passaged nonadherent lymph node cells (over 99.5% 
Ig-negative  by  immunofluorescence;  57%  recovery  of  cells  from  the  nylon  wool  column). 
AKR(R), B6(S): SI 515; AKR(R), SJL(S): SI 184. 
$ Both alloantisera were hyperimmune sera, used at a  final dilution of 1/le,  and absorbed once 
with AKR spleen cells. AKR anti-B6 serum was absorbed three times with SJL and AKR anti- 
SJL serum three times with B6 spleen cells. 
§ Ig+T  + blasts were detected by indirect immunofluorescence (see Materials and Methods), they 
were over 99% T cells and over 97% responder cells (staining with B6 anti-AKR serum), <5% of 
trypsinized  T-cell  blasts  were  Ig  positive  with  alloantisera  after  overnight  incubation  in 
culture medium.  Background staining with normal mouse serum was  <3%. Between 100 and 
300 T-cell blasts were counted. 
II  Percent recovery of cells and percent blasts after overnight recovery from trypsin treatment in 
culture medium and 5 h  incubation with MLR supernate. Recovery: 90% (i); 100% (ii); 40% (iii); 
75% (iv); blasts: 84% (i), 74% (ii), 68% (iii), 63% (iv). 
and  only  5%  of (B6)SJL-T-cell blasts  stained  with  the  Fla(AKRaB6)  serum. 
The latter number of positive blasts was possibly within the background even 
though normal  (AKR  x  B6)F1  serum gave only 1% positive T-cell blasts.  To 
test whether other AKR T-cell blasts reacted with the antiserum, we performed 
immunofluorescent staining with Con A-stimulated AKR spleen cells.  7.9% of 
the Con A-stimulated splenic T-cell blasts were positive. This was within the 
control with normal  (AKR x  B6)F1 serum of 8.2%. 
Further  specificity  tests  also  showed  that  36%  of  (SJL)AKR-T-cell  blasts 
were positive (32% in a  separate experiment).  Our initial assumption was that 
lymphocyte-defined MLR-stimulating determinant (LD) antigens on SJL public 
with B6 could lead to an expansion ofAKR responder T-cell clones with common 
idiotypes. To test this hypothesis, we absorbed the FIa(AKRaB6) serum with an 
equal  number  of either  (B6)AKR-T or  (SJL)AKR-T cell blasts,  respectively, 
and  obtained  the  following data  from  immunofluorescent  staining  with  the 
absorbed  antiserum:  (B6)AKR-T-cell  blast-absorbed  antiserum  stained  only 
8.6% of (B6)AKR-T-cell blasts,  whereas  (SJL)AKR-T-cell blast-absorbed anti- 
serum  still  stained  35.1%  of (B6)AKR-T,  but  only  5.3%  of (SJL)AKR-T-cell 
blasts. These data would be compatible with the above assumption. 
Reactivity  of FIa(AKRaB6)  Serum  with MLR-Activated F~ Hybrid  T  Cells. 
The  crucial  test  of whether  or  not  public  LD  determinants  on  B6  and  SJL 
could lead to stimulation  of some of the  same AKR T  cells and hence to ex- 
pression of the same receptors and idiotypes on these cells is in the staining 30  T-CELL  RECEPTORS  FOR  ALLOANTIGENS 
TABLE II 
Reactivity of Anti-ldiotypic Serum with MLR- or Mitogen-Activated T  Cells 
Cell population 
T-cell  blasts  from MLR§ 
Responder  Stimulator 
Immunofluorescence with 
F,a(AKRaB6) serum* 
Ig-positive  responder 
T-cell  blasts$ 
AKR  B6 
AKR  SJL 
Unabsorbed 
Absorbed  on  (B6)AKR-T 
cell  blasts¶ 
Absorbed on (SJL)AKR-T 
cell  blasts¶ 
% 
(i)65.o1[ 
8.6 
35.1 
Unabsorbed  (ii)36.01[ 
Absorbed  on  (SJL)AKR-T  5.8 
cell blasts¶ 
SJL  B6  Unabsorbed  (iii)  5.01[ 
Con  A-activated  splenic 
T-cell blasts 
AKR**  Unabsorbed  (iv)  7.911 
* The antiserum (unabsorbed and absorbed) was used in a  final dilution of 1/2o. 
Between 100 and 300 blasts were counted. 
§ Responder cells were nylon wool column-passaged nonadherent lymph node cells (over 99.5% 
Ig-negative by immunofluorescence; between 38% and 48% recovery of cells from the nylon 
wool column). AKR(R), B6(S): SI 616, over 99% blasts. AKR(R), SJL(S): SI 306.5, 97% blasts, 
over 99% responder T  cells  (staining with RaT and B6 anti-AKR serum).  SJL(R),  B6(S): SI 
8.5, 91% blasts (over 99% T cells). 
II  Range in three experiments: 65%-84% (i), in two experiments; 32%-36% (ii). Normal (AKR × 
B6)F, serum control: 1.2%  (i); 0.7% (ii); 1% (iii); and 8.2% (iv). 
¶ 50/~l of the antiserum was absorbed twice on 8  ×  10  e MLR.activated T-cell blasts. 
** Activation for 2  days by 5  /~g and 10  ~g Con  A/ml medium.  Blasts were  pooled from both 
cultures and identified as T  cells by RaT.  Sh 24.5  (5  /~g culture),  20.8  (10  ~g culture).  90% 
blasts. 
of  the Fla(AKRaB6) serum on (B6)(AKR × SJL)F,-T and (SJL)(AKR × B6)Fi- 
T-cell  blasts.  The use of  F~ hybrid mice as MLR  responders excludes public  B6 
and SJL LD determinants  responsible for stimulation. Consequently,  if our 
assumption is correct,  (SJL)(AKR  x B6)F,-T-cell  blasts  should not stain  with 
the antiserum. 
The fact  that not only the majority of  (B6)(AKR x SJL)F,-T but also  a large 
number of (SJL)(AKR x B6)F,-T-cell  blasts  were positive  with the antiserum 
(Table III)  does not favor  our assumption. Possibly,  other as yet unidentified 
antibodies  contaminate the antiserum and are mainly responsible  for staining 
of  (SJL)AKR-T and (SJL)(AKR x B6)F,-T cell  blasts.  Data from Table ITI  also 
show that these contaminating antibodies can be removed  by appropriate 
absorptions  without affecting  activity  against idiotype-positive  T-cell  receptors 
for B6 antigens. Absorption of  the F,a(AKRaB6) serum with (B6)AKR-T and 
with (SJL)AKR-T cell  blasts,  respectively,  equally removed the activity  of  the 
antiserum  against  (SJL)(AKR  x  B6)F,-T-cell blasts. In marked  contrast, PETER  H.  KRAMMER  31 
TABLE  HI 
Reactivity of Anti-Idiotypic Serum with MLR-Activated F1 Hybrid T Cells 
Cell population 
T-cell  blasts  from MLR§ 
Responder  Stimulator 
Immunofluorescence with 
Fza(AKRaB6) serum* 
Ig-positive  re- 
sponder T-cell 
blasts$ 
(AKR x  SJL)F1  B6 
(AKR  x  B6)F1  SJL 
% 
Unabsorbed  (i) 8111 
Absorbed  on  (B6)AKR-T-  6.7 
cell  blasts 
Absorbed  on  (SJL)AKR-T-  33 
cell  blasts 
Unabsorbed  (ii)  561[ 
Absorbed  on  (B6)AKR-T-  11 
cell  blasts 
Absorbed  on  (SJL)AKR-T-  11 
cell  blasts 
* For absorption of  the antiserum see Table II.  The antiserum was used in a final  dilution  of  1/15 
on (B6)  (AKR x SJL)FI-T and 1/100  on (SJL) (AKR  x B6)FI-T cell  blasts. 
Between 100 and 300 blasts  were counted. 
§ Responder cells  were nylon wool column-nonadherent lymph node cells  (over  99% Ig-negative 
by immunofluorescence; recovery of cells  from nylon wool column: 40% (AKR  x SJL)FI, 64% 
(AKR x B6)FI. (AKR x SJL)F~(R), B6(S):  98% blasts.  (AKR x B6)F~(R), SJL(S): 84% blasts. 
II Normal (AKR x B6)FI serum control:  negative (i),  and 5% (ii). 
reactivity of the  antiserum with  (B6)(AKR  x  SJL)F1-T  cell blasts  could be 
removed only by absorption with (B6)AKR-T,  and not with (SJL)AKR-T-cell 
blasts.  The  latter  absorption,  however,  reduced  the  number  of  positive 
(B6)(AKR  x  SJL)F~-T-cell blasts from 81% to 33%. 
Competition  of  Alloantigens and F]a(AKRaB6) Antibodies for Binding Sites 
of the Same T-Cell Receptors.  In several experiments we had observed that 
the idiotypic determinants recognized  by the F~a(AKRaB6) serum were removed 
from the  T-cell blast  surface by  trypsin treatment and  resynthesized after 
overnight incubation of the trypsinized blasts in culture medium. In addition, 
the  immunofluorescent staining on  a  large fraction of the  recovered blasts 
seemed to be more intense than on the freshly isolated blasts.  Therefore, we 
performed experiments (a representative example is shown in Table IV) to test 
whether there could be competition (or at least steric hindrance) of alloantigens 
and F~a(AKRaB6)  antibodies for binding sites of T-cell receptors for alloanti- 
gens, i.e. whether alloantigens and anti-idiotypic antibodies bind to the same 
receptor molecules. Idiotype-positive receptors and bound B6 alloantigens were 
demonstrated on (B6)AKR-T-cell  blasts  [68% F~a(AKRaB6)  and 53% B6 posi- 
tive].  Trypsin treatment reduced the  staining  in  both  cases to  background 
levels. After overnight incubation of the trypsin-treated blasts in tissue culture 
medium (without soluble alloantigens), most of the blasts stained very strongly 
with  the  F~a(AKRaB6)  serum.  Bound  B6  alloantigens could  not be  shown 
[71.8% F~a(AKRaB6)  and 2.7% B6 positive]. 
If, however, the trypsin-treated blasts were incubated overnight in an MLR 
supernate  which  contained B6  alloantigens  [MLR:AKR(R),  B6(S)],  a  large 32  T-CELL  RECEPTORS  FOR  ALLOANTIGENS 
number  of the  recovered  (B6)AKR-T-cell  blasts  had  B6  alloantigens  bound, 
whereas  staining  with  Fla(AKRaB6)  serum  was  markedly  reduced  [9% 
F,a(AKRaB6) and 50% B6 positive]. 
To establish the specificity of this inhibition,  we tested whether or not two 
other control MLR supernates could inhibit the reactivity of the F~a(AKRaB6) 
serum with the (B6)AKR-T-cell blasts. These control supernates were from the 
MLR:  (a) AKR(R), AKR(S)  (as a  source of AKR antigens);  and  (b) AKR(R), 
SJL(S) (as a  source of SJL alloantigens).  In both cases, staining with the anti- 
idiotypic serum was only minimally  reduced  [54.5%  and  44.5%  F,a(AKRaB6) 
positive, respectively].  Only 5.4% and  11.8%,  respectively, of the  (B6)AKR-T- 
cell blasts stained for crossreacting alloantigens with AKR anti-B6 serum. The 
number of idiotype-positive (B6)AKR-T-cell blasts in the latter two cases was 
not drastically lower than the number ai~r incubation of the blasts in culture 
medium  alone.  The  inhibition  of  the  staining  of  F,a(AKRaB6)  serum  on 
(B6)AKR-T-cell blasts  mainly with  B6 alloantigens  was  specific,  as  staining 
with rabbit anti-mouse T-cell serum  (RAT) serum on the same blasts was not 
depressed. Soluble B6 alloantigens and Fla(AKRaB6) anti-idiotypic antibodies 
thus seem to bind to the same receptor molecules. 
Reactivity  of  F,a(AKRaB6)  Serum  with  AKR  Anti-B6  Antibodies. 
(SJL)AKR-T-cell blast-absorbed F,a(AKRaB6) serum proved to be specific for 
receptors on (B6)AKR-T and (B6)(AKR ×  SJL)F,-T-cell blasts. To test whether 
or not this antiserum would also specifically react with AKR anti-B6 alloanti- 
bodies,  it was  used for immunofluorescent  staining  of (B6)AKR-T-cell blasts 
after absorption on AKR anti-B6 serum-coupled Sepharose.  Control  stainings 
were done with F~a(AKRaB6) serum absorbed on normal  AKR or AKR anti- 
SJL serum.  It can be seen from Table V that only absorption on AKR anti-B6 
serum-coupled  Sepharose  significantly  reduced  the  number  of  stainable 
(B6)AKR-T-cell blasts-by 75%  (from 46.4% to 11.3%  Ig-positive responder T- 
cell blasts).  This  indicates that  at least a  fraction of AKR anti-B6  antibodies 
share common idiotypic determinants  with T-cell receptors of (B6)AKR-T-cell 
blasts. 
Discussion 
The  experiments  reported  in  this  paper  demonstrated  the  presence  and 
specificity of T-cell receptors for alloantigens  on MLR-activated responder T- 
cell blasts detected by the binding of soluble stimulator cell alloantigens  and 
anti-idiotypic antibodies to the same receptor molecules. 
In accordance with Elliott et al.  (10) we could show that soluble alloantigens 
from MLR supernates specifically bind to responder T-cell blasts after recovery 
of these cells from trypsin treatment,  i.e. the number of (B6)AKR-T-cell blasts 
binding B6 alloantigens was greater than five times the number binding SJL 
alloantigens.  The reverse was seen for (SJL)AKR-T-cell blasts. 
Nevertheless, a small but significant number of (B6)AKR-T- and (SJL)AKR- 
T-cell  blasts bound SJL and  B6 alloantigens,  respectively.  This  binding  was 
detected  with  AKR  anti-SJL  and  AKR  anti-B6  sera  even  after  extensive 
absorption for reactivity with public B6 or SJL SD determinants.  AKR anti-SJL 
serum therefore reacted with private  SJL SD determinants  on SJL alloanti- 
gens bound by a small number of (B6)AKR-T-cell blasts, whereas AKR anti-B6 PETER  H.  KRAMMER  33 
TABI.Z  IV 
Competition of Alloantigens and Anti-ldiotypic Antibodies for Binding  Sites of T-CeU 
Receptors 
Ig-positive  immunofluorescent (B6)AKR-T cell  blasts* 
Sera 
(i)  Isolated  (ii)  After 
from pri-  trypsin 
mary MLR 
treatments 
cultures 
After trypsin  treatment  and subsequent  over- 
night culture  in 
(iii)  Cul- 
ture me- 
diums 
Supernate  from  MLR (AKR T cells 
[R] against [S]) 
(iv) AKR$  (v) SJL$  (vi) B6S 
%  %  %  %  %  % 
F~a(AKRaB6)§  68  5  71.8  54.5  44.5  9 
AKR anti-B6[I  53  3.6  2.7  5.4  11.8  50 
* AKR  responder cells  were nylon wool column-passaged nonadherent lymph node cells  (over 
99% Ig-negative  by immunofluorescence; 71% recovery from the nylon wool column). AKR(R), 
B6(S):  SI 67.8. 
% blasts:  86% (over  99% responder  T cells:  staining  with RaT and B6 anti-AKR serum) (i);  82% 
(ii);  94% (iii);  84% (iv);  89% (v);  and 91% (vi).  Over 99% of  the  blasts  were T cells:  staining  with 
RaT (vi).  Cell  recovery after  trypsin treatment and overnight incubation:  93% (ii),  23% (iii), 
93% (iv),  63% (v),  and 43% (vi).  Between 100 and 300 blasts  per group were counted. In all 
groups control  staining  with (AKR × B6)FI normal serum was below 1%. 
§  The antiserum was used at  a final  dilution  of  1/15. 
I[ The antiserum was used at a final  dilution  of  1/15  and did  not react  with AKR  cells. 
TABLE  V 
Reactivity of Anti-ldiotypic Serum with Alloantibodies 
Cell population 
T-cell  blasts  from MLR§ 
Responder  Stimulator 
Immunofluorescence with FIa(AKRaB6) serum* 
Ig-positive  re- 
sponder  T-cell 
blastsS 
% 
AKR  B6  Unabsorbed  46.3 
AKR  B6  (i) Absorbed on normal AKR seruml[  46.4 
AKR  B6  (ii) Absorbed on AKR anti-SJL serumll  39.7 
AKR  B6  (iii) Absorbed on AKR anti-B6 serum][  11.3 
* The antiserum used in  all  four  groups  was preabsorbed  on (SJL)AKR-T cell  blasts  as described 
in Table II  and used at a final  dilution  of  1/18. 
Between 150 and 300 blasts  were counted. 
§ AKR  responder cells  were nylon wool column-nonadherent lymph node cells  (over  99.5% Ig- 
negative by immunofluorescence; recovery of cells  from nylon wool column: 45%). AKR(R), 
B6(S):  SI 65.6. 
[I The preabsorbed (see  *) FIa(AKRaB6) serum was further  absorbed on normal AKR  serum (i), 
hyperimmune AKR  anti-SJL (ii),  or AKR  anti-B6 serum (iii)  coupled to cyanogen bromide- 
activated  Sepharose as described under Materials and Methods. 
serum  reacted  with  private  B6  SD  determinants  on  B6  alloantigens  bound 
by a  small number  of (SJL)AKR-T-cell blasts. 
These  data  can  probably be  explained  by the  assumption  that  alloantigens 
from MLR supernates  are part of complex membrane  fragments.  Thus,  private 34  T-CELL  RECEPTORS  FOR  ALLOANTIGENS 
SD  determinants  recognized by  our  absorbed  alloantisera  could  physically 
be  linked with  public  determinants recognized by  T-cell  receptors for  allo- 
antigens. This interpretation necessarily implies that alloantibodies and T-cell 
receptors recognize different public histocompatibility determinants. 
With respect to B6 and SJL alloantigen binding by (B6)AKR-T and B6 and 
SJL alloantigen binding by (SJL)AKR-T cell blasts, the question arises whether 
this binding is due to crossreactivity of the T-cell receptors on single cells from 
a small fraction of MLR-activated T-cell blasts, or whether two different types 
of receptors are expressed on separate clones. The observation that responder 
T-cell blasts from an MLR with two histogenetically different stimulator cells 
in  the  same  culture  bind  either  one  or  the  other  type  of stimulator  cell 
alloantigen (9) rather favors the concept of separate clones. 
In addition to alloantigen binding, we studied T-cell receptors for alloantigens 
with anti-idiotypic sera.  Since it has been difficult to raise  such antisera in 
mice with alloantibodies as immunogens, or with parental T cells undergoing a 
GvH response in F1  hybrid mice (13), we tried to raise anti-idiotypic sera by 
repeated  injection of purified MLR-activated responder T-cell blasts  into  F1 
hybrid mice. As the majority of MLR-activated responder T-cell blasts invaria- 
bly carry stimulator cell antigens bound to receptors on the cell surface (see 
above),  F1  hybrid mice  (crosses between the MLR responder and stimulator 
strains) were used as recipients. Thus, we tried to avoid alloantibody production 
against  stimulator alloantigens,  which could have  occurred with  syngeneic 
recipients. Syngeneic recipients for the production of anti-idiotypic sera against 
MLR-activated T-cell blasts were used by Andersson et al.  (22). This provides 
the advantage of testing whether or not the T-cell response of these mice is 
specifically suppressed (tested by MLR) against cells from the MLR stimulator 
strain. This system however, suffers from the disadvantage that a suppressive 
role of alloantibodies against stimulator cells cannot easily be excluded. 
In addition, these authors had generated the MLR-activated T-cell blasts by 
an MLR with an unseparated responder cell population containing T  and B 
cells. We could previously show (9) that the resulting T-cell blasts from such 
an MLR have alloantibodies on the cell surface. These alloantibodies, produced 
by coproliferating responder B cells, are bound to the cell surface of responder 
T-cell  blasts  through  a  bridge  of stimulator  cell  alloantigens  specifically 
attached to the alloantigen receptors of these responder T-cell blasts. The use 
of such blasts  therefore  could lead  to  the  production of a  mixture  of anti- 
idiotypic antibodies which might react with T-cell receptor idiotypes as well as 
with idiotypes of alloantibodies. We wanted to avoid this situation by injecting 
MLR-activated responder T-cell blasts from an MLR with nylon wool column- 
purified lymph node T cells as responders into F~ hybrid mice (crosses between 
MLR respender and stimulator strains).  Our method of raising anti-idiotypic 
sera has by now been successfully reproduced by various experimental groups. 
That is,  FIa(AKRaSJL)  sera gave results similar to F~a(AKRaB6)  sera,  but 
with the reverse specificity. 
In this paper we reported that F~a(AKRaB6) sera have high titered antibodies 
against  idiotypic  determinants  of  T-cell  receptors  from  (B6)AKR-T  and 
(B6)(AKR  ×  SJL)Fl-T-cell blasts against B6 alloantigens. This observation is 
supported  by  the  high  number  of these  T-cell  blasts  which  reacted  with PETER  H.  KRAMMER  35 
F,a(AKRaB6) sera, and by the fact that absorptions of the sera with (SJL)AKR- 
T-cell blasts did not abolish the reaction of the antisera with (B6)AKR-T and 
(B6)(AKR  x  SJL)FrT-cell blasts.  Furthermore, the reaction of the antisera 
with these blasts was specific,  as (B6)SJL-T- and Con A-activated splenic AKR 
T-cell blasts did not react with the antisera above background. 
Nevertheless,  unabsorbed  F,a(AKRaB6)  sera  also  reacted  with  some 
(SJL)AKR-T and  (SJL)(AKR  x  B6)F,-T-cell  blasts.  This  reactivity could in 
both cases be absorbed out equally well with (B6)AKR-T as with (SJL)AKR-T- 
cell  blasts.  These  data  strongly  suggest  that,  together with  anti-idiotypic 
antibodies against AKR or (AKR  x  SJL)F,  receptors for B6 antigens exclu- 
sively, other as yet unidentified contaminating antibodies are present in these 
antisera. Such antibodies could be directed against viral determinants (16) on 
the T-cell blast surface; they could be autoantibodies, antibodies against blast 
antigens, or antibodies against human serum components. We have excluded a 
major role for autoantibodies by concluding that F,a(AKRaB6)  sera did not 
react with normal B6,  (AKR x  B6)F, or (AKR  x  SJL)F, lymph node T cells 
(data not shown) and normal AKR lymph node T cells stained only minimally 
above background (data not shown).  A  high titer of possibly contaminating 
antibodies  against blast  antigens and human serum components eventually 
picked  up  by  the  T-cell  blasts  from  the  MLR  culture  medium is  equally 
unlikely,  as  the  F,a(AKRaB6)  sera  did  not  stain  (B6)SJL-T-  and  Con  A- 
activated splenic AKR T-cell blasts above background. 
Initially, we assumed that F,a(AKRaB6) sera apart from (B6)AKR-T  also 
stained  a fraction  of  (SJL)AKR-T-cell blasts  because public  SJL LD determinants 
with B6 might have stimulated the expression of  receptors  on (SJL)AKR-T-cell 
blasts  with idiotypic  determinants shared by receptors  on some (B6)AKR-T-cell 
blasts.  Even though raised against (B6)AKR-T-cell  blasts,  F,a(AKRaB6) sera 
would recognize these common  idiotypes  on both types of T-cell  blasts.  This 
assumption,  however, was not supported by the fact  that F,a(AKRaB6)  sera 
also stained a sizable number  of (SJL)(AKR  x  B6)FrT-cell blasts. In this 
situation  only private  SJL and not public  SJL LD determinants with B6 could 
have been responsible for MLR  stimulation. If our explanation  had been 
correct, (SJL)(AKR x B6)F,-T-cell  blasts  should have been negative with the 
antisera. 
Alternatively, cross-reactive  idiotypes  could be expressed on a fraction  of 
(B6)AKR-T-, (B6)(AKR x SJL)F,-T-, (SJL)AKR-T-, and (SJL)(AKR x B6)F,- 
T-cell blasts; F,a(AKRaB6) sera  might recognize idiotypic determinants  on 
receptors from MLR  responder cells  against either  modified self  antigens (23) 
or  blast  antigens presented by MLR  stimulator cells  which escaped irradiation. 
Another set of  data bears on the question of  allelic  exclusion.  F,a(AKRaB6) 
sera stained (B6)AKR-T- but not (B6)SJL-T-cell  blasts.  This excludes common 
idiotypes on both types of blasts. Surprisingly, however,  the majority of 
(B6)(AKR x SJL)FrT-cell blasts  were positive.  This might be explained either 
by the absence of  allelic  exclusion  or  by the rather unlikely assumption that in 
this  MLR, only (AKR × SJL)F~ T cells  with AKR-type receptors  responded to 
B6 stimulators. 
As discussed above, alloantigen binding and idiotypic  analysis provide two 
independent probes for T-cell  receptors on MLR-activated T-cell  blasts. We 36  T-CELL RECEPTORS  FOR ALLOANTIGENS 
combined these two approaches to test whether or not anti:idiotypic antibodies 
and alloantigens compete for sites on the receptor molecules on T cells. 
We  could  show  that  idiotype-positive T-cell  receptors on  (B6)AKR-T-cell 
blasts  could be  resynthesized after overnight incubation and recovery from 
trypsin  treatment as  demonstrated by  staining  with  FIa(AKRaB6)  serum. 
Uptake of B6 alloantigens to (B6)AKR-T-cell  blasts aider  trypsin treatment, 
however,  could effectively  block  the staining of (B6)AKR-T-cell  blasts with 
FIa(AKRaB6)  serum. This inhibition was specific,  as demonstrated by lack of 
considerable inhibition  with control  alloantigens.  Alloantigens and anti-idiotypic 
antibodies therefore seem to bind to the same receptor molecules on MLR- 
activated T-cell  blasts. 
The fact  that AKR  anti-B6 serum-coupled Sepharose could specifically  absorb 
out a considerable part of  the reactivity  of  FIa(AKRaB6)  serum with (B6)AKR- 
T-ceU blasts indicates that at least a fraction of alloantibodies share idiotypic 
determinants with receptors on alloreactive T  cells. Whether some or all of 
such  idiotypic determinants  on  T-cell receptors  are  identical to idiotypic 
determinants on alloantibedies can be studied in a radioimmune  assay with 
F~a(AKRaB6)  serum and purified radioactive alloantibodies. Such work is in 
progress in our group. 
Our data provide some information on the specificity  of  T-cell  receptors for 
alloantigens. Alloantigen binding and idiotypic analysis of T-cell receptors 
with antisera raised against idiotypes on receptors of  MLR-activated responder 
T-cell  blasts make possible the direct  study of  T cells  on a single-cell  level.  We 
showed  that it is possible reproducibly  to raise anti-idiotypic  sera in mice. 
These  sera, however,  have  to be vigorously  controlled for specificity.  The 
specificity of the antisera  can be assessed  as reported in this paper.  We 
obtained further specific  controls by functional studies, such as direct MLR 
inhibition by addition of anti-idiotypic  sera to the culture. Data from these 
experiments support the findings in this  study and will  be reported elsewhere. 
We shall  concentrate our future work with these antisera on the genetics of 
T-cell receptor  idiotypes, and the estimation of the precursor frequency of 
alloreactive T  cells.  The latter question could not be approached effectively 
with the fluorescent methodology in this  study due to inherent problems with 
background levels which do not allow correct measurements  of low numbers. 
Finally, the anti-idiotypic  sera shall  provide an excellent tool to screen T-cell 
tumors or  T-cell  tumor/T-cell hybrids for  expression of  receptors  for  alloantigens. 
Summary 
B6 aUoantigens in supernates from one-way mixed lymphocyte  reaction (MLR) 
cultures of AKR T  cells  against B6  lymph node cells rebound specifically to 
(B6)AKR-T-cell blasts after overnight incubation and recovery of these blasts 
from trypsin treatment. A similar specificity was observed with the binding of 
SJL alloantigens to (SJL)AKR-T-cell blasts. In both cases, the corresponding 
alloantigens  were rebound several-fold  more efficiently  than control  alloantigens. 
In a different  assay system, T-cell  receptors were studied with anti-idiotypic 
sera. These antisera were raised by repeated injection  of  purified (B6)AKR-T- 
cell  blasts  into (AKR  x B6)FI hybrid mice. These FIa(AKRaB6)  sera reacted PETER  H.  KRAMMER  37 
with the majority of (B6)AKR-T and (B6)(AKR  ×  SJL)F1-T-cell blasts.  They 
also  reacted  with  a  lower,  though  sizable,  number  of  (SJL)AKR-T-  and 
(SJL)(AKR  ×  B6)F1-T-cell  blasts.  No reaction was observed with (B6)SJL-T, 
concanavalin A-activated AKR T-cell blasts,  normal B6,  (AKR  ×  B6)F,  and 
(AKR  ×  SJL)F1  T  cells.  Normal AKR T  cells were positive only minimally 
above background.  F~a(AKRaB6) sera could be made specific for (B6)AKR-T 
and (B6)(AKR × SJL)F~-T-cell blasts by absorption of  contaminating antibodies 
with (SJL)AKR-T-cell blasts. 
Finally,  it  was  shown  by  competition experiments  that  the  receptors  on 
MLR-activated T-cell blasts that bind alloantigens were the same as those bind- 
ing anti-idiotypic antibodies. In addition, it was found that at least a fraction of 
alloantibodies share  common idiotypic determinants with  receptors  on  MLR- 
activated T-cell blasts. 
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